Thanks for that Novo: and so, revenues should be sufficient to fund the 1801 trials, without bothering too much about the SP, and probably no need for any further dilutions. And don't forget, FDA has already given fast track designation for it.
Also I remember there was a small issue in the 2a trial around "handwashing," kind of ironic eh!
Thanks for that Novo: and so, revenues should be sufficient to...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.005(1.82%) |
Mkt cap ! $433.1M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.5¢ | 27.0¢ | $70.18K | 259.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1431 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 163265 | 6 |
View Market Depth
| Last trade - 10.18am 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.8¢ |
Change
-0.005 ( 1.65 %) |
||||
| Open | High | Low | Volume | ||
| 27.0¢ | 27.0¢ | 26.8¢ | 21082 | ||
| Last updated 10.12am 17/05/2024 ? | |||||
| BOT (ASX) Chart |